(Translated by https://www.hiragana.jp/)
WHO | Vaccine research and development
The Wayback Machine - https://web.archive.org/web/20131208072748/http://www.who.int:80/immunization/research/en/

Immunization, Vaccines and Biologicals

November 2013

Malaria Vaccine Technology Roadmap

The updated Malaria Vaccine Technology Roadmap represents the result of a review process facilitated by WHO, which worked with the Malaria Vaccine Funders Group to update the 2006 roadmap’s vision and strategic goals. The roadmap forms a strategic framework that underpins the activities of the global malaria vaccine research and development community. The updated document maintains the original goal of having a licensed vaccine against Plasmodium falciparum malaria by 2015, and sets a new goal of having a second generation of malaria vaccines licensed by 2030.

May 2013

Through the viral world: From quarks to multiverse

Professor Dominic Man-Kit Lam, Director of the Institute of Creativity of the Hong Kong Baptist University, a world-renowned scientist and a most distinguished Chinese artist, displayed his arts in celebration of the First WHO meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting responses. The meeting was co-organized with Professor Lam and was held at the Lam Woo International Conference Centre at the Hong Kong Baptist University from 24 to 26 January 2013.

7 February 2013

13th Dengue International Course open for registration

WHO/PAHO Collaborating Center for the Study of Dengue and its Vector, is organizing the 13th Dengue International Course from 12 to 23 August 2013 in La Habana, Cuba.
This two-week course includes lectures, seminars and practical sessions on laboratory diagnosis, clinical care, epidemiology, vector control and community participation activities. In addition, there will be symposia dedicated to dengue diagnosis, dengue clinical management, vaccine development and dengue surveillance among others.

14 November 2012

MenAfriVac® is the first vaccine to gain approval to travel outside cold chain

Sylvestre Tiendrebeogo/WHO

The meningococcal A conjugate vaccine known as MenAfriVac® can now be kept in a controlled temperature chain at temperatures of up to 40°C for up to four days. With this new regulatory approval, this innovative vaccine, which costs less than US$0.50 per dose, could help increase vaccination campaign efficiency and coverage.

Vaccine research news

Initiatives and forums

WHO-UNAIDS HIV Vaccine Initiative

The WHO-UNAIDS HIV Vaccine Initiative is a joint activity of the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

IVR Global Vaccine Research Forum

The forum serves to bring together a world-wide selection of top researchers and scientists to discuss vaccine research and development issues, and to update research agendas.

Latest publications

  • WHO/IVB/12.09
    31 October 2012
    Report of the HPV Vaccine Delivery Meeting: Identifying Needs for Implementation & Research

Vaccine research highlights

Contact us

Initiative for Vaccine Research
Immunization, Vaccines and Biologicals
World Health Organization (WHO)
20 Avenue Appia
1211 Geneva 27
Switzerland
Fax: +41 (22) 791 48 60
Email: VaccineResearch@who.int

For information on vaccination requirements for international travellers, please visit the WHO international travelers pages